SCHEMBL4324422

SCHEMBL4324422

O=C1N=NC=C1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7215897 0.65
SCHEMBL3754347 0.65
SCHEMBL4328507 0.65
SCHEMBL563998 0.63
SCHEMBL11883487 0.63
SCHEMBL11137968 0.63
SCHEMBL8056119 0.63
SCHEMBL6550677 0.60
SCHEMBL8418471 0.60
SCHEMBL15233768 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3356344-B1 ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY ASTEX THERAPEUTICS LTD (GB) 2022-11-16 EP disclosed
CN-108473464-B Isoindolinone inhibitors of MDM2-P53 interaction with anti-cancer activity 阿斯泰克斯治疗有限公司 2022-08-23 CN disclosed
US-20220106287-A1 ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY ASTEX THERAPEUTICS LIMITED (GB) 2022-04-07 US disclosed
US-11261171-B1 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity ASTEX THERAPEUTICS LIMITED (GB) 2022-03-01 US disclosed
CN-109970752-B Synthesis method of chiral 4-spiro pyrazole compound 浙江工业大学 2020-11-13 CN disclosed
CN-109970752-A A kind of synthetic method of chirality 4- loop coil pyrazole compound 浙江工业大学 2019-07-05 CN disclosed
US-20090069340-A1 Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders ASTRAZENECA AB (SE) 2009-03-12 US disclosed
CN-101128435-A Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders ASTRAZENECA AB (SE) 2008-02-20 CN disclosed
EP-1833800-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed
EP-0087388-B1 PYRAZOLONE COUPLERS AND COLOUR PHOTOGRAPHIC SILVER HALIDE RECORDING MATERIAL CONTAINING THEM CIBA-GEIGY AG (CH) 1986-06-25 EP disclosed
EP-0087388-A1 Pyrazolone couplers and colour photographic silver halide recording material containing them CIBA-GEIGY AG (CH) 1983-08-31 EP disclosed
US-4262087-A USING TWO EQUIVALENTS OF SILVER MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1981-04-14 US disclosed